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Abstract 
Spondylodiscitis has gained attention 
lately because of an alarming and 
progressive increasing of its incidence, 
reflecting the rise of percentage of the 
elderly and immunocompromised people, 
and the implementation in practice of 
advanced diagnostic methods. This review 
will focus on the etiology, diagnostic 
challenges, and treatment strategies in 
spondylodiscitis. The incidence of 
spondylodiscitis is currently 4-24/1 million, 
making up to 3-5 % of total osteomyelitis 
cases. It is approximately two times more 
common in men than in women. 
Staphylococcus aureus is involved in 48 % -
62.5 % of cases of spondylodiscitis. The 
clinical picture is dominated by spinal pain 
and stiffness, and increased erythrocytes 
sedimentation ratio and C-reactive protein 
are laboratory markers of spondylodiscitis. 
The most sensitive imaging method is 
magnetic resonance imaging. 
Bacteriological examination is very 
important for proper and effective 
treatment, guiding the selection of the 
antibacterial regiment that has proven to be 
effective in about 75 % of patients. In other 
cases, surgical treatment may be used. The 
prognosis is favorable, except for those with 
comorbidities or noncompliance with 
treatment. 
 
Key words: spondylodiscitis; discitis; 
disc infection. 
Introduction 
Infection of the intervertebral disc is a 
little studied problem, and which endangers 
in a significant extent the health and quality 
of life of patients if untreated. In the reason 
of a quasi-permanent association of the 
vertebral body inflammation, to define the 
disk infection further, “spondylodiscitis” 
term will be used. Spondylodiscitis has 
gained attention lately because of an 
alarming and progressive increasing of its 
incidence, (1) reflecting the rise of number 
of the elderly and immunocompromised 
people, and the implementation in practice 
of advanced diagnostic methods. The 
absolute number of spondylodiscitis cases 
also increases progressively in close 
accordance with the raise in the number of 
spine interventions. (2) Non-specificity of 
the clinical picture, clinical setting of 
appearance and the unfamiliarity of medical 
staff with this disease, often exclude 
spondylodiscitis from clinical reasoning of 
neurologists. (3) Delayed diagnosis can 
have disastrous consequences for the 
patient, disability and permanent 
deformation of the spine being the possible 
scenario. The management of 
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spondylodiscitis is also a subject of many 
controversies incited by the absence of 
clinical guidelines and treatment protocols. 
The incidence of spontaneous infectious 
spondylodiscitis has a bimodal distribution 
with peaks at ages under 20 years and in 
people after age of 50 years, (1) global 
values of incidence in developed countries 
varying in the range of 4-24 to 1 million 
populations (3) and make up from 3 % to 5 
% of the total number of osteomyelitis. (4) 
The distribution by sex reflects a slight 
prevalence in men, their ratio to women 
being 1,5:1 (5, 6) or 2:1. (7, 8) The mean 
age of patients with postoperative 
spondylodiscitis tends to be lower than that 
of patients with spontaneous 
spondylodiscitis (60-69 versus 46-52 years). 
(7-9) 
Spondylodiscitis is an inflammation of 
the intervertebral disc and neighboring 
vertebrae. The sequence of involvement in 
the process of these structures depends 
largely on their anatomical structure, 
chemical composition, and vascularization. 
There are three possible scenarios for the 
development of spondylodiscitis: primary 
infection of intervertebral disc by 
hematogenous spread of bacteria, vertebral 
body primary infection, or direct 
inoculation of the pathogen in the disc. The 
first mechanism is characteristic for 
spondylodiscitis in children, the rich 
vascularity of the intervertebral disc 
contributing to the precipitation of the 
pathogen at this level, often the infectious 
process being limited to this area, in which 
case we talk about pure discitis. Also, such a 
development of the events may be possible 
in the elderly, (10) where the disc capsule, 
by virtue of degenerative processes, 
becomes vulnerable to microbial invasion. 
The second scenario is observed in adults. 
In such cases the intervertebral disc is 
largely avascular, and vascularization of the 
lamina terminalis has already begun to 
suffer from loss of intraosseous 
anastomoses, so that it creates the 
possibility of a primary infection of 
subchondral bone, which by destroying the 
lamina terminalis will propagate to adjacent 
intervertebral disc. (11) Infection by direct 
inoculation is seen in iatrogenic 
spondylodiscitis. The propagation of germs 
in hematogenous spondylodiscitis can occur 
via arterial flow and, rarely, venous 
circulation. The source or site of entry of 
the infection is most often the skin (21 %), 
followed by the genitourinary (10 %) (5) 
and intestinal (12) tracts. However, in 53 % 
of cases of infection the site of entry 
remains unidentified. (5) 
Diagnostic challenges  
The spondylodiscitis diagnosis rate at 
first visit to the physician is discouraging 
small, reaching only 39 % of cases. (5) 
Given the non-specificity and nebulosity of 
symptoms at onset, the most common 
destination of visits of patients with 
spondylodiscitis is primary care units (66.7 
%). (13) As a result, diagnostic failure 
worsens because of unawareness and 
reduced vigilance of physicians for this 
disease. The same is true for 
endocrinologists who have the mission to 
fight the prevailing background of 
spondylodiscitis - diabetes mellitus. The 
time between the start of symptoms and the 
establishment of diagnosis in different 
studies ranged from 2 days to 12 months, 
(9, 14, 15) with an average of 4.3 months, 
(16) being higher in patients with 
postoperative spondylodiscitis. (8) 
One explanation is the similarity of 
clinical (pain) and laboratory (erythrocytes 
sedimentation rate (ESR), C-reactive 
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protein (CRP)) markers of spondylodiscitis 
and the normal postoperative changes. (17) 
Achieving ESR peak at day 5 of surgery and 
returning to normal in the first 3 weeks is a 
normal postoperative dynamic and any 
digression from this rhythm would raise 
suspicion. (18) Given the prompt dynamic 
of changes of C-reactive protein (peak at 
day 3 and returning to normal in the first 2 
weeks), this parameter may be more useful 
than ESR in detecting early deviations from 
normal postoperative course. (18) In 
addition, the presence of neurological 
deficit in patients with spondylodiscitis 
increases confusion by directing the clinical 
reasoning to a post-operative relapse or 
failure of surgery, especially in the presence 
of pain with radicular distribution. (19) 
Lack of fever in many patients with 
postoperative spondylodiscitis (8, 19) 
results in ignoring the infectious nature of 
observed changes. Finally, the imaging 
changes in spondylodiscitis can be included 
in the normal postoperative picture, (20) 
although the identification of vertebral 
edema on MRI has determined the 
usefulness of this method in differentiating 
between the two situations. (18) 
Hazy clinical picture, slow evolution, 
and atypical symptoms (lack of systemic 
inflammatory reaction and fever) are 
responsible for the retard in the diagnosis of 
tuberculous spondylodiscitis, reaching an 
average of 6-8 months. (21, 22) For atypical 
and suspicious cases is recommended to 
repeat MRI over 1-2 weeks, during which 
specific changes of spondylodiscitis can be 
delineated. (B2) (10, 21) 
Etiology  
In the etiology of spondylodiscitis 
usually is involved a single organism, 
although multibacterial infection has been 
reported occasionally, especially on an 
immunocompromised or diseased 
background. (12) The most often isolated 
germ has been Staphylococcus with a 
frequency of 48 % - 62.5 %. (8, 9, 23) Most 
of the community acquired Staphylococci 
are sensitive to methicillin and about 30-40 
% of nosocomial staphylococcal infections 
are methicillin-resistant. (24) Next in 
frequency are Gram-negative bacilli (4-30 
%) and streptococci / enterococci (5-30 %). 
(21, 25, 26) Gram-negative bacilli are 
commonly seen on an 
immunocompromised background or after 
infections of gastrointestinal or 
genitourinary tracts, (21, 24, 26) while 
anaerobic infections are more common in 
diabetic patients. (27) Fungal infections are 
the cause of about 1 % of non-tuberculous 
spondylodiscitis in adults, the leading role 
played by Candida albicans (21) and usually 
occur on a background prone to this type of 
infection such as immunosuppression, 
diabetes, broad-spectrum antibiotics or 
treatment in intensive care units. (21, 26, 
28) Brucella gain attention in certain 
geographical areas such as the 
Mediterranean coast, where some studies 
have demonstrated involvement in 25-50 % 
of cases of spinal infection. (15, 22) The 
most common risk factor in developing 
spondylodiscitis is diabetes mellitus. (7, 13, 
15) Among other contributing factors are 
pathological states accompanied by 
immunosuppression (chronic alcoholism, 
(7, 9) prolonged steroidal or non-steroidal 
anti-inflammatory drug therapy, (8) 
intercurrent infections etc.), cardiovascular 
diseases, obesity, (4) Crohn's disease, (12) 
cirrhosis, (29) cancer, (9) intravenous drug 
use (15) etc. 
Clinical picture 
The clinical picture of spondylodiscitis 
often lacks conclusiveness and sometimes is 
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confusing, unless pain and spinal stiffness is 
present. Spontaneous nonspecific 
spondylodiscitis develop acutely, as opposed 
to specific infections that determine a 
blurred clinical picture and has a slow 
evolution. (30) In the course of 
postoperative spondylodiscitis, one can 
distinguish a clinically silent period 
following surgery, lasting on average 21 
days and ranging from hours to months. (7) 
Low back pain with inflammatory character 
(83-100 % of cases) (5, 8, 9) is the most 
common cause of visits to the physician, 
(14, 16) and sometimes is absent in patients 
with spontaneous spondylodiscitis. (8) The 
features of spondylodiscitis pain (the 
nocturnal character, resistant to painkillers 
and rest, (28) associated with morning 
stiffness and worsening at bed shaking – 
bed-shaking test (7)) has a diagnostic utility. 
Pain intensity is less relevant, varying from 
moderate to severe. (7) Pain usually is 
located in the affected region of the spine 
but can radiate into the buttocks, thighs, 
abdomen, or perineal region. (7) 
Anatomical distribution of the infection has 
a downward character, lumbar region being 
involved in 38-70 % of cases. (5, 8, 9, 31) 
Spinal stiffness, present in 77-100 % of 
cases, (5, 7, 9) aims to reduce the burden on 
anterior vertebral elements. (4) The 
systemic inflammatory syndrome is 
reflected by increased body temperature 
(observed in 50-97 % of cases), (5, 8, 9) 
profuse sweating, weight loss etc. The 
neurological deficit is present in most cases 
of postoperative spondylodiscitis and only 
in half of those with spontaneous 
spondylodiscitis. (8, 16) It is more common 
in cervical and thoracic locations of the 
infectious process (25) and in cases of 
tuberculous nature, (22) reflecting in an 
indirect way the causal relationship to the 
formation of paravertebral collections, (13) 
whose frequency was found to be increased 
in higher segments, (25, 32) and in patients 
with specific infectious. (30, 33, 34)  
Investigations 
One of the first changed and the most 
faithful marker of spondylodiscitis is ESR, 
which proved to be increased in 98-100 % 
of cases. (5, 7, 15) Even if the ESR did not 
correlate with severity of disease, (33) the 
dynamics of this parameter was found to be 
useful in assessing the response to the 
treatment. C-reactive protein is a marker as 
reliable as ESR, some authors (35) 
considering it to be even more sensitive 
than ESR, being increased in almost all 
cases (7, 15) of spondylodiscitis. The 
dynamics of these changes is more 
important than their absolute value, both to 
monitor the patient's clinical condition and 
to assess treatment efficacy. So, returning to 
normal ESR and CRP was observed on 
average 21 days (7) after the initiation of a 
successful treatment. Leukocytosis is an 
inconstant parameter, with a frequency of 
42-64 % of cases. (5, 25) 
The simplest and most accessible 
method of isolation of the infectious agent 
is blood culture. Resultativity of blood 
culture is enhanced by the increased 
virulence of pathogens, (29) the 
spontaneous nature of spondylodiscitis, (8) 
the multiplicity of performed sowing (at 
least three), (A2) (4, 21) carrying out during 
fever peak or within 4 hours after puncture 
of the intervertebral disc, (26, 36) and is 
drastically reduced by prior antibiotic drugs 
therapy, in which cases is recommended to 
postpone the sampling for at least 2 weeks 
after cessation of antibacterial therapy. (A3) 
(21) Given the low success rates of 
haemoculture in postoperative 
spondylodiscitis, (7) SPILF guideline 
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recommends disco-vertebral biopsy in any 
suspicions of spondylodiscitis after 
intradiscal surgery. (A2) (21) Urine, 
sputum, and samples from any site of entry 
are needed to detect possible sources of 
primary infection. (37) Three successive 
failed inseminations is an indication for the 
use of disc puncture. The procedure is 
done under anesthesia and radiological 
(computerized tomography) guidance, (4) 
with a success rate of 60-70 %. (14, 26, 35, 
38, 39) Like blood culture, the disc 
puncture is compromised by prior 
antibiotic therapy. (21, 24) To increase the 
quality of the collected material, multiple 
sampling is recommended, two of the top 
terminal lamina, two of the bottom one and 
two from the intervertebral disc. (21) If the 
first disc puncture proves to be negative, it 
is recommended to repeat the procedure. 
(6, 40) Open biopsy is necessary if 
percutaneous puncture and empirical 
treatment have both failed (28). Serological 
investigations are not recommended to be 
performed routinely given their low success 
rate. (24) 
Imaging  
1. Radiography 
Usefulness of radiography in diagnosing 
spondylodiscitis in overall is low, and lies in 
highlighting the pinching of the 
intervertebral space and progressive 
subchondral sclerosis in association with an 
increased adjacent bone density, (33) which 
in the later stages can pass into geodes, 
compressions or vertebral collapse. 
Broadening of the psoas shadow, 
mediastinum or retroperitoneal space is a 
sign of spreading of the infection to 
paravertebral tissues. (27) 
2. Computerized tomography 
In the first 2 weeks in 50 % of patients 
(21) computerized tomography (CT) 
reveals pinching and hipodensity of affected 
disc, erosion of the vertebral lamina and the 
vertebral body and soft tissue edema. (36, 
38, 41) (figure 1) CT usefulness is evident 
in guiding the disc biopsies or drainage of 
paravertebral collections. (37) Contrast 
administration will facilitate highlighting of 
paravertebral infiltration and fluid 
collection. (42) 
 
 
Figure 1 Computerized tomography (axial view) of 
the lumbar spine showing erosions of the vertebral 
lamina and the vertebral body. It is noticeable the 
sparing of the posterior elements of the vertebra 
 
 
Figure 2 Magnetic resonance imaging (MRI) of the 
lumbar spine in a patient with spondylodiscitis: A. 
T1-weighted sequence showing destruction of 
lamina terminalis and vertebral edema; B. T2-
weighted MRI revealing intradiscal hyperintensities 
(white arrow) and epidural abscess (black arrow); C. 
Contrasting of intervertebral disc (arrowhead) on 
contrast-enhanced T1-weighted MRI 
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3. Magnetic resonance imaging 
Magnetic resonance imaging (MRI), 
considered to be the method of choice for 
early detection of changes in bacterial 
spondylodiscitis, (14, 21, 43) provides a 
number of criteria which are distinguished 
by high sensitivity and specificity: presence 
of epidural or paraspinal inflammation 
(sensitivity 97.7 %), contrasting of the 
intervertebral disc in T1-weighted 
sequences (sensitivity 95.4 %), 
hyperintensities or fluid signal intensities in 
the intervertebral disc in T2-weighted MRI 
(sensitivity 93.2 %) and erosions and 
destructions of at least one vertebral lamina 
terminalis (sensitivity 84.1 %). (44) (figure 
2, A, B, C) Other signs include the 
disappearance of intranuclear hypodense slit 
in T2-weighted MRI, epiduritis (epidural 
abscess) viewed as an epidural 
hypointensity in T1 and hyperintensity in 
T2-weighted images and paravertebral 
abscess (T1 hyperintense and T2 
hypointense signals in the lateral vertebral 
regions). (9) Anterior location of imaging 
changes in spontaneous spondylodiscitis 
and posterior situation of these changes in 
postoperative forms is a common regularity. 
(8) Usefulness of MRI in monitoring the 
progress and response to treatment of 
spondylodiscitis was discredited except in 
epiduritis and paravertebral abscess, 
imaging appearance of which correlated 
with clinical parameters and laboratory 
dynamics. (9) For patients in whom MRI is 
contraindicated (i.e. implanted pacemaker), 
French guidelines recommend obtaining 
contrast scintigraphy followed by CT. (21) 
4. Other 
Scintigraphy is not the method of 
choice, (45) while other authors consider it 
useful in the diagnosis of spondylodiscitis, 
especially in the elderly. (36) Extreme 
usefulness of positron emission 
tomography (PET) with Fluorine-18 
fluorodeoxyglucose (18-F FDG) in 
revealing inflammatory process in the 
vertebral body (4) is counteracted by the 
high cost of this method and the inability to 
differentiate between a tumor and an 
inflammatory process. (45) 
Differential diagnosis  
Differentiating spondylodiscitis from the 
degenerative changes of Modic I type is 
occasionally difficult, (46) given the 
similarity of imaging and clinical data. (46) 
Intradiscal fluid hyperintensities in T2 
sequences, the erosions and destructions of 
the lamina terminalis, and the formation of 
paravertebral collections, (44) is the MRI 
picture that will lead us to the diagnosis of 
spondylodiscitis, given the rarity of 
degenerative origins of such changes. MRI 
with diffusion and F-18 FDG PET are 
useful in this context by revealing 
inflammatory changes with a hyperintense 
in the first case (47) and hypermetabolic in 
the second, (4) appearance. Coupling the 
imaging with the clinical (pain with 
inflammatory rhythm, fever, sweating) and 
laboratory (ESR and CRP increase) data, 
will increase the potential for 
discrimination between the two 
pathologies. However, one should not 
overlook the possibility of development of 
spondylodiscitis in a degenerated disc, (48) 
witch is one of the few situations when 
isolated discitis can develop in adults.  
The diagnosis of spondylodiscitis is 
sometimes evoked in the context of an 
injury other than infectious, such as 
seronegative spondyloarthritis, including 
ankylosing (49) and enteropathic (50) 
spondylitis. Spondylodiscitis developed on 
this pathologic background is distinguished 
from the bacterial variant of the disease by 
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the absence of a localized pain and systemic 
inflammatory syndrome. In addition, the 
anatomical location of spondylodiscitis in 
ankylosing spondylitis is predominantly the 
lower chest segment and multiple levels of 
injury are more commonly seen than in the 
analogue of bacterial origin. (49) 
Spondylodiscitis incidence in ankylosing 
spondylitis is estimated around 8 %. (49) 
Treatment 
1. General rules 
Given the lack of prospective 
randomized trials, the treatment of 
spondylodiscitis remains controversial until 
today. (24) The success of conservative 
treatment was documented in 
approximately 73 % of patients with 
spondylodiscitis. (23) The crucial elements 
of a successful treatment of spondylodiscitis 
are the immobilization of the affected 
segment of the spine, antibiotics and 
(depending on the severity of disease) 
debridement and decompression of the 
spinal canal. (4) Targeted antibacterial 
treatment is a fundamental element in the 
management of spondylodiscitis and 
identification of pathogens must precede 
always the elaboration of an individual 
treatment scheme, (4) except in cases of 
sepsis, with critical clinical status, 
neutropenia or severe neurological deficit, 
(37) which will require the use of empirical 
treatment.  
2. Selection of the antibiotics 
In the selection of the antibiotic, its 
ability to penetrate bone and intervertebral 
disc tissue should be taken into 
consideration, as is well known that 
fluoroquinolones, clindamycin, rifampicin, 
fusidic acid, and metronidazole reach 
remarkable bone concentrations. The 
penetrability of beta-lactams and 
glycopeptides is moderate, while 
aminoglycosides does penetrate bone even 
worse. (24) However, penetrability into the 
intervertebral disc correlates with 
antibiotic’s ion charge, negatively charged 
antibiotics such as penicillin being far less 
penetrating than the positively charged ones 
such as gentamicin. (51) In this framework 
of ideas, the ability of antibiotics to diffuse 
in disc tissue in decreasing order is as 
follows: clindamycin and aminoglycosides 
> quinolones and glycopeptides> 
penicillins and cephalosporins. (51) 
However, the value of such data in 
establishing antibacterial regime is unclear, 
once SPILF guideline recommends as first-
line treatment of staphylococcal infections 
penicillin and glycopeptides, (21) antibiotics 
that has been shown to penetrate 
moderately/poorly in disc tissue. (52) 
Taking as support the result of 
bacteriologic exams, antibiotic selection 
within each therapeutic group will be 
guided by pharmacokinetic profile, ability 
to penetrate the disc and bone tissue, route 
of administration, toxicity, and cost. Thus, 
greater oral bioavailability will favor the 
selection of cloxacillin over oxacillin for the 
treatment per os. (53) Netilmicin was 
preferred among other aminoglycosides to 
treat infections with Gram + bacteria, since 
the former has less ototoxicity while 
teicoplanin was preferred over vancomycin 
because of nephrotoxicity and more 
complicated use of second. (54) Also, 
ciprofloxacin should be favored over other 
fluorchinolones in the treatment of 
infections caused by Pseudomonas 
aeruginosa or other Gram- bacteria, since it 
possesses the lowest minimum inhibitory 
concentration for these bacteria. (55) Some 
authors recommend metronidazole for 
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anaerobic etiology, (24, 56) while others 
plead in favor of clindamycin. (21) 
3. Duration of the treatment 
Duration of parenteral antibacterial 
therapy has been adjusted depending on the 
level of C-reactive protein, normalization of 
this parameter in the first two weeks 
requiring parenteral treatment cessation, or 
its prolongation to 3 weeks otherwise. (43) 
Switch to oral administration after 
achieving clinical improvement or 
normalization or considerable decrease of 
biological markers of inflammation (ESR, 
CRP, WBC) was a tactic favored by other 
authors. (4) Oral bioavailability of 
clindamycin, fluoroquinolones, rifampicin 
and fusidic acid is high, (57) so they are a 
good choice for maintenance treatment, 
and are not recommended for the initial 
treatment because of the potential for 
developing resistant strains. (24) 
Duration of oral antibiotic treatment is 
from 6 weeks to 3 months for nonspecific 
spondylodiscitis (23) and 2 times longer, 
(30) typically up to one year, (15) in 
tuberculous cases. Paravertebral collections 
will sometimes require percutaneous or 
surgical drainage. Surgery is rarely 
necessary and only in cases where spinal 
instability, (23, 32) progressive neurological 
deficit, (13, 23) failure of conservative 
treatment (4) or cauda equina syndrome 
(13) are present. Antibacterial prophylaxis 
of spondylodiscitis is imperative after any 
intradiscal surgery. (58) 
Prognostics 
Residual symptoms may persist both 
after conservative and surgical treatment of 
spondylodiscitis. The recurrence rate of 
spondylodiscitis was reported to be between 
0 % and 7 %. (59, 60) Adverse outcomes are 
related to septic complications, (16) being 
more common in patients with a premorbid 
background such as diabetes. (31) 
Conclusions 
Spondylodiscitis is an issue whose 
importance on the one hand is often 
underestimated or missed and on the other 
hand is getting worse every year in the 
context of an increase in the number of 
spine interventions as well as in the 
prevalence of elderly and immune-
compromised subjects. The diagnosis of 
spondylodiscitis is sometimes difficult, and 
knowledge of clinical features and atypical 
forms is essential for accurate and early 
diagnosis. At the forefront of the diagnostic 
labor in spondylodiscitis are imaging (MRI) 
and bacteriologic exams. The keystone of 
an effective treatment of spondylodiscitis 
will be always the microbiological 
examinations and in cases where they fail it 
will be adjusted depending on the most 
likely etiology of the disease derived from 
the present clinical situation and guided by 
the results of previous clinical studies. 
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